#Biotech stocks last week started on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including $PFE &amp; $MRK who disappointed by lowering its outlook, but sell-side stayed positive on the prospects. #MarkeNews https://t.co/SYedZP3WxN